Application Nr Approved Date Route Status External Links
NDA021395 None Respiratory (Inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Spiriva Handihaler (Tiotropium Bromide Inhalation Powder) Is Indicated For The Long-Term, Once-Daily, Maintenance Treatment Of Bronchospasm Associated With Chronic Obstructive Pulmonary Disease (Copd), Including Chronic Bronchitis And Emphysema. Spiriva Handihaler Is Indicated To Reduce Exacerbations In Copd Patients. Spiriva Handihaler Is An Anticholinergic Indicated For The Long-Term, Once-Daily, Maintenance Treatment Of Bronchospasm Associated With Chronic Obstructive Pulmonary Disease (Copd), And For Reducing Copd Exacerbations ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tiotropium Bromide Monohydrate

Comments